{"name": "Anthera Pharmaceuticals",
 "permalink": "anthera-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/anthera-pharmaceuticals",
 "homepage_url": "http://www.anthera.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2004,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@anthera.com",
 "phone_number": "510-856-5600",
 "description": "",
 "created_at": "Tue Feb 23 04:07:24 UTC 2010",
 "updated_at": "Mon Nov 01 03:06:01 UTC 2010",
 "overview": "\u003Cp\u003EAnthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat diseases associated with inflammation, including cardiovascular and autoimmune diseases. Its primary product candidates include varespladib methyl (A-002), which has completed its Phase 2 clinical studies for the treatment of acute coronary syndrome; varespladib sodium (A-001) that is in a Phase 2 clinical study for the prevention of acute chest syndrome associated with sickle cell disease; and A-623, which has completed Phase 1 clinical studies for the treatment of B-cell mediated autoimmune diseases. The company has license agreements with Eli Lilly and Company, and Shionogi \u0026amp; Co., Ltd. to develop and commercialize secretory phospholipase A2 or sPLA2 inhibitors for the treatment of cardiovascular disease and other diseases; and Amgen Inc., to develop and commercialize A-623. Anthera Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Hayward, California.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       43],
      "assets/images/resized/0007/7869/77869v1-max-150x150.png"],
     [[212,
       61],
      "assets/images/resized/0007/7869/77869v1-max-250x250.png"],
     [[212,
       61],
      "assets/images/resized/0007/7869/77869v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Paul",
      "last_name": "F. Truex",
      "permalink": "paul-f-truex",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Christopher",
      "last_name": "P. Lowe",
      "permalink": "christopher-p-lowe",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$31.5M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://investor.anthera.com/releasedetail.cfm?ReleaseID=509533",
    "source_description": "Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing",
    "raised_amount": 31500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 9,
    "funded_day": 21,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Caxton Associates",
         "permalink": "caxton-associates",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0027/0086/270086v1-max-150x150.png"],
             [[227,
               61],
              "assets/images/resized/0027/0086/270086v1-max-250x250.png"],
             [[227,
               61],
              "assets/images/resized/0027/0086/270086v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "25801 Industrial Blvd",
    "address2": "Suite B",
    "zip_code": "94545",
    "city": "Hayward",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Anthera looks to raise $70M with IPO",
    "stoned_year": 2010,
    "stoned_month": 2,
    "stoned_day": 22,
    "source_url": "http://www.fiercebiotech.com/story/anthera-looks-raise-70m-ipo/2010-02-22?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "Anthera looks to raise $70M with IPO",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Anthera Pharmaceuticals",
      "permalink": "anthera-pharmaceuticals"}},
   {"description": "OrbiMed Joins $31.5M PIPE For Anthera Pharmaceuticals",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 22,
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020100922e69m00004\u0026r=Rss\u0026s=DJFVLS",
    "source_text": "",
    "source_description": "OrbiMed Joins $31.5M PIPE For Anthera Pharmaceuticals",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Anthera Pharmaceuticals",
      "permalink": "anthera-pharmaceuticals"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": 2010,
   "pub_month": 3,
   "pub_day": 1,
   "stock_symbol": "NASDAQ:ANTH"},
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        91],
       "assets/images/resized/0007/7868/77868v1-max-150x150.jpg"],
      [[250,
        152],
       "assets/images/resized/0007/7868/77868v1-max-250x250.jpg"],
      [[450,
        274],
       "assets/images/resized/0007/7868/77868v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}